Outcomes Based on Timing of Progression After CAR T-Cell Therapy. PFS (A) and OS (B) since treatment for the first progression (PFS2 and OS2) in the TL-post-CAR-T set according to early (≤6 months) vs late (>6 months) TAFA-LEN introduction. CI, confidence interval; NA, not available.